← Back to Search

Polyphenols

Blueberries for Metabolic Syndrome

N/A
Waitlist Available
Led By Marie-Claude Vohl
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least one of the following: BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
Be between 18 and 65 years old
Must not have
Use of antibiotics in the last 3 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial will study whether blueberries can help prevent obesity-linked metabolic syndrome by looking at the microbes in the gut and the metabolites produced.

Who is the study for?
This trial is for Caucasian men and premenopausal women in good health, with a BMI of 25-40 or waist circumference over 80 cm for women and 94 cm for men. Participants must have high triglycerides or fasting insulin levels. Exclusions include heavy drinkers, recent surgery or antibiotic use, smokers, certain medication users, metabolic disorder sufferers, blueberry allergies/intolerances, significant weight change recently, or special diets.
What is being tested?
The study tests if daily consumption of either real blueberry powder or a placebo affects the gut microbiota and can help prevent obesity-related metabolic syndrome. It combines genetic material analysis (metagenomics), gene expression profiling (transcriptomics), and small molecule characterization (metabolomics) to understand how blueberries might benefit heart and metabolic health.
What are the potential side effects?
Since this trial involves consuming blueberry powder which is generally considered safe as part of a regular diet; no significant side effects are expected beyond potential allergic reactions in those sensitive to blueberries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is between 25 and 40, or my waist size meets the criteria.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not taken antibiotics in the last 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Blueberry powderExperimental Treatment1 Intervention
Group II: Blueberry placebo powderPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
434 Previous Clinical Trials
178,579 Total Patients Enrolled
26 Trials studying Metabolic Syndrome
1,956 Patients Enrolled for Metabolic Syndrome
Marie-Claude VohlPrincipal InvestigatorLaval University
3 Previous Clinical Trials
123 Total Patients Enrolled
2 Trials studying Metabolic Syndrome
100 Patients Enrolled for Metabolic Syndrome

Media Library

Blueberry Powder (Polyphenols) Clinical Trial Eligibility Overview. Trial Name: NCT03266055 — N/A
Metabolic Syndrome Research Study Groups: Blueberry powder, Blueberry placebo powder
Metabolic Syndrome Clinical Trial 2023: Blueberry Powder Highlights & Side Effects. Trial Name: NCT03266055 — N/A
Blueberry Powder (Polyphenols) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03266055 — N/A
~7 spots leftby Dec 2025